These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 29921235)

  • 1. TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association.
    Zonneville J; Safina A; Truskinovsky AM; Arteaga CL; Bakin AV
    BMC Cancer; 2018 Jun; 18(1):670. PubMed ID: 29921235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-fibroblast interactions stimulate tumor vascularization by enhancing cytokine-driven production of MMP9 by tumor cells.
    Limoge M; Safina A; Beattie A; Kapus L; Truskinovsky AM; Bakin AV
    Oncotarget; 2017 May; 8(22):35592-35608. PubMed ID: 28423685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
    Shrivastav S; Bal A; Singh G; Joshi K
    Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential TGF-{beta} signaling in retinal vascular cells: a role in diabetic retinopathy?
    Van Geest RJ; Klaassen I; Vogels IM; Van Noorden CJ; Schlingemann RO
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1857-65. PubMed ID: 19959647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction.
    Alex L; Tuleta I; Hernandez SC; Hanna A; Venugopal H; Astorkia M; Humeres C; Kubota A; Su K; Zheng D; Frangogiannis NG
    Circulation; 2023 Sep; 148(11):882-898. PubMed ID: 37350296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression.
    Franco M; Roswall P; Cortez E; Hanahan D; Pietras K
    Blood; 2011 Sep; 118(10):2906-17. PubMed ID: 21778339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.
    Keskin D; Kim J; Cooke VG; Wu CC; Sugimoto H; Gu C; De Palma M; Kalluri R; LeBleu VS
    Cell Rep; 2015 Feb; 10(7):1066-81. PubMed ID: 25704811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
    Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX
    Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma.
    Lu C; Kamat AA; Lin YG; Merritt WM; Landen CN; Kim TJ; Spannuth W; Arumugam T; Han LY; Jennings NB; Logsdon C; Jaffe RB; Coleman RL; Sood AK
    Clin Cancer Res; 2007 Jul; 13(14):4209-17. PubMed ID: 17634550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.
    Lin SL; Chang FC; Schrimpf C; Chen YT; Wu CF; Wu VC; Chiang WC; Kuhnert F; Kuo CJ; Chen YM; Wu KD; Tsai TJ; Duffield JS
    Am J Pathol; 2011 Feb; 178(2):911-23. PubMed ID: 21281822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.
    Sennino B; Falcón BL; McCauley D; Le T; McCauley T; Kurz JC; Haskell A; Epstein DM; McDonald DM
    Cancer Res; 2007 Aug; 67(15):7358-67. PubMed ID: 17671206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.
    Lugo R; Gabasa M; Andriani F; Puig M; Facchinetti F; Ramírez J; Gómez-Caro A; Pastorino U; Fuster G; Almendros I; Gascón P; Davalos A; Reguart N; Roz L; Alcaraz J
    Oncotarget; 2016 Dec; 7(50):82324-82337. PubMed ID: 27384989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of TGFβ-Mediated Repression of Angiopoietin-2 in Pericytes Underlies Germinal Matrix Hemorrhage Pathogenesis.
    Dave JM; Chakraborty R; Agyemang A; Ntokou A; Saito J; Ballabh P; Martin KA; Greif DM
    Stroke; 2024 Sep; 55(9):2340-2352. PubMed ID: 39129597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion.
    Navarro R; Tapia-Galisteo A; Martín-García L; Tarín C; Corbacho C; Gómez-López G; Sánchez-Tirado E; Campuzano S; González-Cortés A; Yáñez-Sedeño P; Compte M; Álvarez-Vallina L; Sanz L
    Mol Oncol; 2020 Oct; 14(10):2609-2628. PubMed ID: 32767843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
    Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
    Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pericyte ALK5/TIMP3 Axis Contributes to Endothelial Morphogenesis in the Developing Brain.
    Dave JM; Mirabella T; Weatherbee SD; Greif DM
    Dev Cell; 2018 Mar; 44(6):665-678.e6. PubMed ID: 29456135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells.
    Safina A; Vandette E; Bakin AV
    Oncogene; 2007 Apr; 26(17):2407-22. PubMed ID: 17072348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactomedin-like 3 promotes PDGF-dependent pericyte proliferation and migration during embryonic blood vessel formation.
    Imhof BA; Ballet R; Hammel P; Jemelin S; Garrido-Urbani S; Ikeya M; Matthes T; Miljkovic-Licina M
    FASEB J; 2020 Nov; 34(11):15559-15576. PubMed ID: 32997357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
    Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
    Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.